It's coming. Quote from Stan:
"I have been impressed by the interest from a number of multinational world class vaccine companies who recognize us as the leader in RSV vaccine development."
T'was nice, as soon as I put BearBowelMove, et al on ignore, it made this forum so much more readable. Noticed this morning there were 9 posts on the first page that were legit and 9 posts that were blocked. Don't miss the strange LOL, LMAO references in broken english. Life's good!
You guys may hear me making comparisons to IONS (formerly ISIS). I do it because I owned the stock. Best of my recollection was that it was a $7 stock for a good while. They got their first FDA approval on a drug to treat a hypercholesterol issue. Not sure of the number of afflicted patients but not by any means a huge number as it is a rare disease. Those afflicted by the condition have serious health conditions by age 35 and some die prior to age 40. IONS got FDA approval in the U.S. (for Kynamro) WITH A BLACKBOX WARNING FOR AE's. It was rejected in the EU because of the AE's. But the main thing was that it had it's first antisense drug proven that it could make it to market. From those $7 days, IONS/ISIS made a slow/steady run over $70. It has since fallen back to the $40's but the move was made because the platform/company had finally proven itself that it could bring a drug through FDA approval. Given HBV market potential, imagine what it will be like for us. IONS has gone on to partner clinical trials with GSK/Bayer (Cardiovascular), AZ & OncoGenex (Cancer), Huntingtons Disease (Roche), etc. More than 34 clinicals in the pipeline. Do your own due diligence and by all means never buy a stock because some on a YMB told you it has potential.
I haven't been a Trump supporter but the "Crooked Hillary" moniker will stick to her like napalm (mainly because it's true). Trump has branded all of his opponents and brought all of them down (Little Marco, Crazy Ben, "Low Energy" Jeb, Lyin' Ted...). If you leave fast enough the door won't get cha' in the rear. At least with Trump you and your OS alum will have a chance at a job, otherwise it will just be more of the same old tired (pathetic) story.
Nice call! If we hold, Bullish signal confirmed today. Dirk wetting pants and having tantrum on Twitter. Nice contrarian indicator.
We long timers have seen bear raids that were more like car jackings. No joke. Like the current trend. Slow and steady. Beats the hell out of what we have endured in the past....
FOLKS, place your bets here. Call the date that the CLOSING price of ARWR will surpass the closing price for ALNY. Since you are all so shy, I'll go first. My prediction: February 29th, 2017. ARWR to move up and ALNY to get a pretty severe haircut. Too many AE's for their drugs, too many missteps on their execution. #CantWait
are "all shook up"!
OUABRA45 TRANSLATION: You should miss a 75% move (to $9.23) to be sure that the "uptrend" is confirmed.
We're the leader in HepB AND we knock out tumors! BooyaCaSha. Here's the money line. We can't be bought!
80% knockdown of HIF-2α mRNA and significant tumor growth inhibition. Histological examination of tumor sections showed substantial cell killing and destruction of tumor architecture.
Did you guys read the Motley Fool article released today? The Headline and the Conclusion are total contradictions. The writer is all over the map although comes to a positive conclusion. There are no certainties in business. Stan just needs to deliver the goods.
That's the sound of (convincingly) breaking through $6. Ross Perot once referenced "that giant sucking sound". That's the life going out of the shorts. Love to see 'em (finally) squirm. FUG'EM.
Sure, one "ridiculous confusing answer" was you saying in previous posts that the uptrend was not going to be confirmed UNTIL we breached $9.23. Now that you are long, it's just simply the next "resistance" level. Been in the stock for more than a year and a half and I still believe in it. Thanks for the priceless advice Johnny (come lately).
Just Tweeted 25 seconds ago:
@RNAiAnalyst forgot 1 other scenario:home-run seroconversion data, then financing,but prob too late for that. Arrowbutts squeezing me 2day
So we are the world's leader in the HBV race AND we knock out cancer! Was just looking at some historical charts. Amazing that we were a $16 stock in Sept. 2014. That was a fair valuation. People are blind, but hey, more opportunity for us! :)
Our platform is superior, more precise with fewer AE's.